Alkyl Amines Chemicals Ltd.
NSE: ALKYLAMINE · Chemicals
Sector
Chemicals
Size band
Small cap
Market cap
6,822cr
P/E
37.8
ROE
14%
Dividend yield
0.7%
No price is shown on this page, live or delayed. It records what management said on the earnings call, and the company’s filings.
Measured against
Peer set
Speciality Chemicals · largest 12 of 32 measured at Q1 FY27 · financials via Screener| Company | Operating margin | Revenue growth |
|---|---|---|
| Gujarat Fluorochemicals Ltd. | 27.0% | 24.0% |
| Navin Fluorine International Ltd. | 34.0% | 44.1% |
| Atul Ltd. | 21.0% | 25.0% |
| Aarti Industries Ltd. | 16.0% | 42.5% |
| Aether Industries Ltd. | 31.0% | 27.2% |
| Anupam Rasayan India Ltd. | 25.0% | 34.8% |
| Vinati Organics Ltd. | 24.0% | 28.4% |
| Privi Speciality Chemicals Ltd. | 23.0% | 19.1% |
| Jubilant Ingrevia Ltd. | 15.0% | 25.2% |
| Clean Science And Technology Ltd. | 36.0% | 10.3% |
| Alkyl Amines Chemicals Ltd. | 25.0% | 30.0% |
| Epigral Ltd. | 25.0% | 16.1% |
No guidance on record.
This section quotes what management told the market on the quarterly earnings call. We have not transcribed one for Alkyl Amines Chemicals Ltd..
On air
2 calls · outcomes not trackedRecorded as stated on air, with the analyst's SEBI registration status where it was given. Anchor calls carry no registration and are marked. Bharatstox does not make, endorse or repeat these calls, and none of them is our view.
| Channel & show | Aired | Stated target | Stated stop | Outcome |
|---|---|---|---|---|
| Zee BusinessZee Business · no registration attached | 2 Sep | +6.0% | -3.4% | still open |
| Zee BusinessZee Business · no registration attached | 2 Sep | +3.6% | -3.4% | still open |
Shareholding
change across 4 filings| Category | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Change |
|---|---|---|---|---|---|
| Promoters | 72.0 | 72.1 | 72.0 | 72.0 | 0.0 |
| Foreign institutions | 3.5 | 3.5 | 3.5 | 3.4 | +0.1 |
| Domestic institutions | 3.1 | 3.0 | 3.0 | 2.9 | +0.2 |
| Retail & others | 21.4 | 21.5 | 21.5 | 21.7 | −0.3 |
As filed with the exchange for the periods ending Sep 25 to Jun 26.
Filings
latest 25 of 166- Certificate under SEBI (Depositories and Participants) Regulations, 20188 Oct 2026
- Spurt in Volume7 Oct 2026
- Spurt in Volume6 Oct 2026RoutineGeneral
- Copy of Newspaper Publication30 Sept 2026
- Trading Window24 Sept 2026
- Shareholders meeting21 Sept 2026
- Voting Results of Postal Ballot along with the Report issued by the Scrutinizer21 Sept 2026
- ESOP/ESOS/ESPS17 Sept 2026
- As per attachment17 Sept 2026
- Copy of Newspaper Publication19 Aug 2026
- Shareholders meeting18 Aug 2026
- Change in Director(s)4 Aug 2026
- Outcome of Board Meeting4 Aug 2026
- Copy of Newspaper Publication29 Jul 2026
- Shareholders meeting7 Jul 2026
- Certificate under SEBI (Depositories and Participants) Regulations, 20187 Jul 2026
- Shareholders meeting3 Jul 2026
- ESOP/ESOS/ESPS16 Jun 2026
- Copy of Newspaper Publication10 Jun 2026
- Updates9 Jun 2026
- Updates9 Jun 2026
- Shareholders meeting9 Jun 2026
- Disclosure under SEBI Takeover Regulations5 Jun 2026
- Spurt in Volume3 Jun 2026
- Spurt in Volume2 Jun 2026RoutineGeneral
The 25 most recent of 166 filings we hold for ALKYLAMINE, back to January 2024. Every filing, by day.
Disclaimer
Guidance is quoted from management commentary on quarterly earnings calls; the words are the company's own and the targets are theirs, not ours. Peer comparisons use quarterly financials sourced from Screener, with every company measured at the same fiscal quarter; the peer set is companies sharing the same industry classification, and comparisons are descriptive, not a ranking or a view. Broadcast calls are reproduced as stated on air, attributed, with the analyst's SEBI registration status where given; they are not our calls and not our view. Filings are reproduced as companies filed them to the NSE and BSE; Bharatstox does not verify, endorse or comment on their contents. This page is for informational and educational purposes only and does not constitute investment advice, research, or a recommendation to buy or sell any security. Investing in securities markets is subject to market risks. Read all related documents carefully before investing.